<?xml version="1.0" encoding="UTF-8"?>
<p>However, there are also some studies suspecting the ability of MC to improve the disorder of glucose metabolism. In 2007, a RCT on type 2 diabetics elucidated the issue regarding the hypoglycemic effects of MC for the first time. It is concluded that the difference in average change in HbA1c between MC capsules and placebo was 0.22%, with the hypoglycemic power being lower than 11% [
 <xref rid="B111" ref-type="bibr">111</xref>]. Then, in 2009, a RCT in nondiabetic overweight men demonstrated that acute, single oral administration of MC powder was useless for insulin or blood glucose and energy expenditure [
 <xref rid="B112" ref-type="bibr">112</xref>]. Cochrane systematic reviews in 2010 [
 <xref rid="B113" ref-type="bibr">113</xref>] and 2012 [
 <xref rid="B114" ref-type="bibr">114</xref>] both reported that there was not enough evidence to suggest MC for type 2 diabetes at that time. However, a systematic review and meta-analysis in 2019 drew the opposite conclusion, but the quality of evidence was low [
 <xref rid="B25" ref-type="bibr">25</xref>].
</p>
